Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04726332
Title Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exelixis
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.